FDA Inspection 1166046 — HMD Investment Group
The FDA completed an inspection of HMD Investment Group on Feb 25, 2022 in Doral, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Tobacco.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 25, 2022
- Fiscal Year
- 2022
- Product Type
- Tobacco
- Project Area
- Tobacco Post-Market Activities
- Location
- Doral, FL (United States)